CDNF | Friday, April 24th 2020CDNF is essential for enteric neuronal development, maintenance, and regulation of gastrointestinal transit
Chalazonitis et al. J. Comp. Neurol. 2020.
AbstractFull text
CDNF | Monday, March 23rd 2020MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine System
Pakarinen et al. eNeuro. 7(1), 2020.
AbstractFree full text
CDNF | Monday, March 23rd 2020Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice
Lindahl et al. Neurobiol. Dis. 134:104696, 2020.
AbstractFree full text
CDNF | Tuesday, December 3rd 2019Levels of Glial Cell Line-Derived Neurotrophic Factor Are Decreased, but Fibroblast Growth Factor 2 and Cerebral Dopamine Neurotrophic Factor Are Increased in the Hippocampus in Parkinson’s Disease
Virachit et al. Brain Pathol. 29:813–825, 2019.
AbstractFull text
CDNF | Friday, November 29th 2019Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function
Danilova et al. Front. Endocrinol. 10:765, 2019.
AbstractFree full text
CDNF | Saturday, September 21st 2019Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease
Galli et al. Front. Neurosci. 13:929, 2019.
AbstractFree full text
CDNF | Friday, May 17th 2019CDNF Protein Therapy in Parkinson’s Disease
Huttunen H and Saarma M. Cell Transplant. 28:349–366, 2019.
AbstractFree full text
CDNF | Monday, May 6th 2019Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy
Galli et al. Cell Transplant. 28:413–424, 2019.
AbstractFree full text
CDNF | Saturday, September 15th 2018Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats
Renko et al. Mol. Neurobiol. 55:6755–6768, 2018.
AbstractFree full text
CDNF | Monday, April 23rd 2018Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson’s Disease
Huotarinen et al. Neuroscience 374:250–263, 2018
AbstractFree full text